<DOC>
	<DOCNO>NCT00984399</DOCNO>
	<brief_summary>The purpose study see Vagifem® 10mcg safe woman breast cancer . Vagifem estrogen product . It tiny tablet insert vagina . It relieve vaginal dryness . Women breast cancer usually tell take estrogen . This estrogen use lead breast cancer recurrence new primary breast cancer . It unclear estrogen Vagifem absorb vagina . It may absorb blood stream short time may cause brief rise estrogen level . However , clear evidence would cause bad effect patient breast cancer . How much , , topical estrogen absorb vagina know . We also know impact low dose estrogen absorption breast cancer outcome . Also , absorption decrease mucus membrane restore estrogen exposure .</brief_summary>
	<brief_title>Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors Vaginal Estrogen</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>History breast cancer , stag IIII pathology confirm MSKCC Women complete primary treatment ( surgery , radiation therapy , adjuvant chemotherapy ) exception endocrine therapy currently clinical evidence disease . Women currently aromatase inhibitor least three monthseither letrozole anastrozole Women symptomatic urogenital atrophy : vaginal dryness , irritation , pruritus , dyspareunia , urinary frequency and/or urinary incontinence Menopausal study entry define : Bilateral salpingooophorectomy independent age If natural menopause , age ≥ 50 cessation menses least 12 month If menopause induce chemotherapy , age ≥ 50 menstrual period least 12 month chemotherapy finish At least 18 year age Able participate inform consent process Gynecology examination within six month Able read/speak English Inability give inform consent Vaginal bleeding unknown etiology within 12 month study entry History prior vaginal 17β estradiol topical estrogen use within past six month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>vaginitis</keyword>
	<keyword>Postmenopausal</keyword>
	<keyword>17-β estradiol</keyword>
	<keyword>09-110</keyword>
</DOC>